The Value of Liver and Spleen Stiffness for Evaluation of Portal Hypertension in Compensated Cirrhosis-Reference-Cited by-同舟云学术

The Value of Liver and Spleen Stiffness for Evaluation of Portal Hypertension in Compensated Cirrhosis

Published:2021-12-14 Issue: Volume: Page:
ISSN:2471-254X
Container-title:Hepatology Communications
language:en
Short-container-title:Hepatol Commun

Author:

Reiberger Thomas¹²³^ORCID

Affiliation:

1. Division of Gastroenterology and Hepatology Department of Internal Medicine III Medical University of Vienna Vienna Austria

2. Vienna Hepatic Hemodynamic Laboratory Division of Gastroenterology and Hepatology Department of Internal Medicine III Medical University of Vienna Vienna Austria

3. Christian‐Doppler Laboratory for Portal Hypertension and Liver Fibrosis Medical University of Vienna Vienna Austria

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hep4.1855

Reference120 articles.

1. The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017

2. Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016–2030

3. NASH Is the Most Rapidly Growing Etiology for Acute‐on‐Chronic Liver Failure‐Related Hospitalization and Disease Burden in the United States: A Population‐Based Study

4. Portal hypertensive bleeding in cirrhosis: Risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases

5. Natural history and prognostic indicators of survival in cirrhosis: A systematic review of 118 studies

Cited by 75 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Performance of spleen stiffness measurement by 100‐Hz vibration‐controlled transient elastography, liver stiffness, APRI score and their combination for predicting oesophageal varices in liver cirrhosis;Clinics and Research in Hepatology and Gastroenterology;2024-10

2. Editorial: Tracking the course of Wilson's disease: Authors' reply;Alimentary Pharmacology & Therapeutics;2024-08-09

3. EASL position paper on clinical follow-up after HCV cure;Journal of Hepatology;2024-08

4. Prognostic indicators and risk factors for the in-hospital mortality rate of patients with cirrhosis;International Journal of Gastrointestinal Intervention;2024-07-31

5. Prevention of Decompensation in Compensated Cirrhosis: Non-Selective Beta-Blockers for Everyone?;EMJ Hepatology;2024-07-18